Cargando…
Laser Treatment for Diabetic Macular Edema in the 21(st) Century
Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population. The diabetes Control and Complications Trial reported that 27% of patients affected by type 1 diabetes develop DME within 9 years of onset. Other studies have shown that in patients with type 2 diabetes, the p...
Autores principales: | Romero-Aroca, Pedro, Reyes-Torres, Javier, Baget-Bernaldiz, Marc, Blasco-Suñe, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051253/ https://www.ncbi.nlm.nih.gov/pubmed/24852439 http://dx.doi.org/10.2174/1573399810666140402123026 |
Ejemplares similares
-
Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab
por: Baget-Bernaldiz, Marc, et al.
Publicado: (2017) -
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
por: Romero-Aroca, Pedro, et al.
Publicado: (2016) -
Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
por: Romero-Aroca, Pedro, et al.
Publicado: (2022) -
Is Laser Photocoagulation Treatment Currently Useful in Diabetic Macular Edema?
por: Romero-Aroca, Pere
Publicado: (2015) -
Targeting the Pathophysiology of Diabetic Macular Edema
por: Romero-Aroca, Pedro
Publicado: (2010)